Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

US$105.21
FV
75.6% undervalued intrinsic discount
12.30%
Revenue growth p.a.
10users have liked this narrative
0users have commented on this narrative
55users have followed this narrative
9 days ago author updated this narrative
US$28.58
FV
63.9% undervalued intrinsic discount
139.00%
Revenue growth p.a.
61users have liked this narrative
0users have commented on this narrative
127users have followed this narrative
2 days ago author updated this narrative
SEK 88.31
FV
15.3% undervalued intrinsic discount
1.26%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative
US$300.00
FV
18.1% undervalued intrinsic discount
9.04%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
4 days ago author updated this narrative
CC logo
Chemours
WA
WaneInvestmentHouse
Community Contributor

Chemours projects $825M-$975M adjusted EBITDA for 2025 with focus on cost savings

The Chemours Company ( CC ), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2024. Key Fourth Quarter 2024 Results & Highlights Net Sales of $1.4 billion, in line with the corresponding prior-year quarter, with TSS achieving record fourth quarter Net Sales, driven by year-over-year growth of 23% in Opteon™ Refrigerants Net Loss attributable to Chemours of $8 million, or $0.05 per diluted share, compared with a Net Loss attributable to Chemours of $18 million, or $0.12 per diluted share, in the corresponding prior-year quarter Adjusted Net Income1 of $16 million, or $0.11 per diluted share, compared with $46 million, or $0.31 per diluted share, in the corresponding prior-year quarter Adjusted EBITDA1,2 of $179 million compared to $176 million in the corresponding prior-year quarter Cash returned to shareholders through dividends of $36 million in the quarter Key Full Year 2024 Results & Highlights Net Sales of $5.8 billion compared to $6.1 billion in the prior year Net Income attributable to Chemours of $86 million, or $0.57 per diluted share, compared with a Net Loss attributable to Chemours of $238 million, or $1.60 per diluted share, in the prior year3 Adjusted Net Income1 of $182 million, or $1.21 per diluted share, compared to $425 million, or $2.82 per diluted share, in the prior year3 Adjusted EBITDA1,2 of $786 million compared to $1.0 billion in the prior year Cash returned to shareholders through dividends of $148 million in the year Established new executive leadership team and announced Chemours’ Pathway to Thrive strategy to drive shareholder value Announced PCC Group’s plans to build a chlor-alkali facility at Chemours’ TiO2 plant in DeLisle, Mississippi and completed our planned Opteon™ YF expansion at Corpus Christi, Texas Fully remediated all four material weaknesses in internal control previously identified in the 2023 Form 10-K Full Year 2025 Outlook4 Adjusted EBITDA between $825 million and $975 million Capital expenditures between $250 million to $300 million
View narrative
US$21.07
FV
20.5% undervalued intrinsic discount
11.25%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
4 days ago author updated this narrative
€101.17
FV
5.1% overvalued intrinsic discount
0.01%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
4 days ago author updated this narrative
SEK 48.17
FV
21.1% undervalued intrinsic discount
6.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
4 days ago author updated this narrative